Sophia GENETICS SA current report, Q1 FY2022

Filing Overview

SOPHiA GENETICS SA filed a Form 6-K as a foreign private issuer for the month of March 2022. The report was signed and filed on March 14, 2022. It references Exhibit 99.1, a press release dated March 14, 2022, but the press release text is not included in the provided filing content.

Financial Information

The provided filing text does not include revenue, profit, cash flow, margins, debt, liquidity, operating results, or other financial metrics.

Changes Versus Prior Period

The filing text does not provide financial or operational comparisons with a prior comparable period.

Guidance, Outlook, Risks, and Unusual Items

No guidance, outlook, management commentary, risks, contingencies, or unusual items are described in the provided text. Any such information may be contained in the referenced Exhibit 99.1, which is not included.

Investor Verification Items

  • Obtain and review Exhibit 99.1, the March 14, 2022 press release.
  • Verify whether the press release contains financial results, guidance, business updates, or material events.
  • Consult the company’s applicable Form 20-F and other filings for complete financial and risk disclosures.